Literature DB >> 7653491

Management of severe exacerbations of asthma.

C A Manthous1.   

Abstract

Asthma is a common disease that afflicts as many as 5% of Americans. Severe exacerbations of asthma can be life-threatening if not treated aggressively. Despite publication of therapeutic guidelines developed by experts in this field, the clinical management of severe exacerbations of asthma varies widely among institutions and practitioners. This article briefly reviews the pathophysiology of asthma and outlines a systematic, mechanistic approach to treating patients with severe asthma that integrates many clinical advancements made during the past 5 to 10 years.

Entities:  

Mesh:

Year:  1995        PMID: 7653491     DOI: 10.1016/s0002-9343(99)80163-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Status asthmaticus. From the emergency department to the intensive care unit.

Authors:  N Kenyon; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  Acute severe asthma: new approaches to assessment and treatment.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Christina Triantafillidou; Iraklis Tsangaris
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 3.  Clinical review: severe asthma.

Authors:  Spyros Papiris; Anastasia Kotanidou; Katerina Malagari; Charis Roussos
Journal:  Crit Care       Date:  2001-11-22       Impact factor: 9.097

4.  The effects of treatment in patients with childhood asthma on the elastic properties of the aorta.

Authors:  Osman Bektaş; Zeki Yüksel Günaydin; Ahmet Karagöz; Recep Akgedik; Adil Bayramoğlu; Ahmet Kaya
Journal:  Cardiovasc J Afr       Date:  2017 May/Jun       Impact factor: 1.167

5.  Outcome of patients with severe asthma in the intensive care unit.

Authors:  Abdulaziz Alzeer; Ahmed BaHammam; Mohammed Masood; Sayed Jani Basha; Esam Alhamad; Sayed Sohail
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.